peptide t has been researched along with peptide t amide in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (21.43) | 18.7374 |
1990's | 5 (35.71) | 18.2507 |
2000's | 3 (21.43) | 29.6817 |
2010's | 3 (21.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dzierzanowska-Madalińska, D; Imielska, D; Kupryszewski, G; Maćkiewicz, Z; Madaliński, K; Walczak, M | 1 |
Burke, TR; Knight, M; Mack, GD; Perkins, R | 1 |
Banks, WA; Barrera, CM; Kastin, AJ | 1 |
Burke, TR; Knight, M | 1 |
Amidon, GL; Su, SF | 1 |
Anderson, WB; Evain-Brion, D; Liapi, C; Raynaud, F; Takahashi, N | 1 |
Farber, EM; Raychaudhuri, SK; Raychaudhuri, SP | 1 |
Brenneman, DE; Hauser, J; Pert, CB; Phillips, TM; Ruff, M; Spong, CY | 1 |
Leoung, GS; Pert, CB; Polianova, M; Ruff, MR; Ruscetti, FW; Yang, QE | 1 |
Pert, CB; Polianova, MT; Ruff, MR; Ruscetti, FW | 1 |
Asthana, D; Atkinson, JH; Goodkin, K; Heseltine, PN; Khamis, I; Lyman, WD; Molina, R; Shapshak, P; Vitiello, B; Wilkie, FL; Zheng, W | 1 |
Fukazawa, Y; Kiguchi, N; Kishioka, S; Kobayashi, Y; Saika, F | 1 |
Baamonde, A; Hidalgo, A; Lastra, A; Meana, Á; Menéndez, L; Pevida, M | 1 |
Chen, J; Li, H; Li, L; Liu, K; Shen, Y; Zhi, D | 1 |
1 review(s) available for peptide t and peptide t amide
Article | Year |
---|---|
Update on D-ala-peptide T-amide (DAPTA): a viral entry inhibitor that blocks CCR5 chemokine receptors.
Topics: CCR5 Receptor Antagonists; Clinical Trials, Phase II as Topic; HIV Infections; HIV-1; Humans; Peptide T; Receptors, HIV; Virus Replication | 2003 |
2 trial(s) available for peptide t and peptide t amide
Article | Year |
---|---|
Anti-chemotactic activities of peptide-T: a possible mechanism of actions for its therapeutic effects on psoriasis.
Topics: Adult; Chemokine CCL5; Chemotaxis, Leukocyte; Female; Humans; Male; Middle Aged; Monocytes; Peptide T; Psoriasis; T-Lymphocytes | 1998 |
Cerebrospinal and peripheral human immunodeficiency virus type 1 load in a multisite, randomized, double-blind, placebo-controlled trial of D-Ala1-peptide T-amide for HIV-1-associated cognitive-motor impairment.
Topics: Adolescent; Adult; AIDS Dementia Complex; Cerebrospinal Fluid; Female; HIV-1; Humans; Leukocyte Count; Male; Monocytes; Peptide T; Plasma; Reproducibility of Results; Serum; Treatment Outcome; Viral Load | 2006 |
11 other study(ies) available for peptide t and peptide t amide
Article | Year |
---|---|
The influence of D-Ala1-peptide T amide, an analogue of HIV glycoprotein 120 fragment, on the CD4--anti CD4 lymphocyte interaction.
Topics: Amino Acid Sequence; Antigen-Antibody Reactions; Binding Sites; Binding, Competitive; HIV Envelope Protein gp120; Humans; In Vitro Techniques; Lymphocytes; Molecular Sequence Data; Peptide T; Receptors, HIV | 1991 |
Reversed-phase preparative chromatography of [D-Ala1]-peptide T amide.
Topics: Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Oligopeptides; Peptide T | 1988 |
D-[Ala1]-peptide T-amide is transported from blood to brain by a saturable system.
Topics: Animals; Blood-Brain Barrier; Chromatography, High Pressure Liquid; Iodine Radioisotopes; Kinetics; Male; Mice; Mice, Inbred ICR; Oligopeptides; Peptide T; Technetium Tc 99m Aggregated Albumin | 1987 |
Counter-current chromatographic purification of [D-Ala]peptide T amide.
Topics: Chromatography, High Pressure Liquid; Countercurrent Distribution; Oligopeptides; Peptide T | 1987 |
Investigation into the intestinal metabolism of [D-Ala1] peptide T amide: implication for oral drug delivery.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Amino Acid Sequence; Animals; Hydrogen-Ion Concentration; Intestinal Absorption; Intestine, Small; Male; Microvilli; Molecular Sequence Data; Peptide Fragments; Peptide T; Perfusion; Protease Inhibitors; Rabbits; Rats; Rats, Sprague-Dawley | 1995 |
Effects of [D-Ala1] peptide T-NH2 and HIV envelope glycoprotein gp120 on cyclic AMP dependent protein kinases in normal and psoriatic human fibroblasts.
Topics: Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Fibroblasts; HIV Envelope Protein gp120; Humans; Peptide T; Psoriasis; Reference Values; Skin | 1998 |
VIP and D-ala-peptide T-amide release chemokines which prevent HIV-1 GP120-induced neuronal death.
Topics: Animals; Cell Death; Cells, Cultured; Chemokine CCL5; Chemokines; Genetic Variation; HIV; HIV Envelope Protein gp120; Neurons; Neurotoxins; Peptide T; Rats; Vasoactive Intestinal Peptide | 1999 |
Chemokine receptor-5 (CCR5) is a receptor for the HIV entry inhibitor peptide T (DAPTA).
Topics: CCR5 Receptor Antagonists; Cell Line; HIV Infections; HIV-1; Humans; Peptide T; Receptors, CCR5; Virus Replication | 2005 |
CC-chemokine ligand 4/macrophage inflammatory protein-1β participates in the induction of neuropathic pain after peripheral nerve injury.
Topics: Animals; CCR5 Receptor Antagonists; Chemokine CCL4; Hyperalgesia; Macrophages; Male; Mice; Mice, Inbred ICR; Neuralgia; Peptide T; Peripheral Nerve Injuries; Receptors, CCR5; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Schwann Cells; Sciatic Nerve; Sciatic Neuropathy; Up-Regulation | 2012 |
The chemokine CCL5 induces CCR1-mediated hyperalgesia in mice inoculated with NCTC 2472 tumoral cells.
Topics: Analysis of Variance; Animals; Bone Neoplasms; Cell Line, Tumor; Chemokine CCL5; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Functional Laterality; Gene Expression Regulation, Neoplastic; Hyperalgesia; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Neoplasm Transplantation; Pain Measurement; Pain Threshold; Peptide T; Receptors, CCR1; Xanthenes | 2014 |
Effects of CC-chemokine receptor 5 on ROCK2 and P-MLC2 expression after focal cerebral ischaemia-reperfusion injury in rats.
Topics: Analysis of Variance; Animals; Brain Infarction; Cardiac Myosins; Disease Models, Animal; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Male; Myosin Light Chains; Neurologic Examination; Peptide T; Rats; Rats, Sprague-Dawley; Receptors, CCR5; Reperfusion Injury; rho-Associated Kinases; Serine | 2016 |